GFR estimation in lenalidomide treatment of multiple myeloma patients: a prospective cohort study

Keyphrases

• Prospective Cohort Study 100%
• Lenalidomide 100%
• Multiple Myeloma Patients 100%
• GFR Estimation 100%
• Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 87%
• CKD Stage 62%
• Estimated Glomerular Filtration Rate 50%
• Myeloma 37%
• Renal Function 25%
• Epidemiology 12%
• Rate Dependence 12%
• Patient Cohort 12%
• Multiple Myeloma 12%
• Minor Differences 12%
• Immunomodulatory Drugs (IMiDs) 12%
• Modification of Diet in Renal Disease 12%
• Drug Dosage 12%
• Baseline Renal Function 12%
• MDRD Equation 12%
• Hematological Diseases 12%

Medicine and Dentistry

• Multiple Myeloma 100%
• Prospective Cohort Study 100%
• Lenalidomide 100%
• Glomerular Filtration Rate 50%
• Kidney Function 37%
• Myeloma 37%
• Nephropathy 12%
• Cohort Effect 12%
• Sulfhemoglobinemia 12%
• Immunomodulatory Drug 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Prospective Cohort Study 100%
• Multiple Myeloma 100%
• Lenalidomide 100%
• Myeloma 37%
• Kidney Disease 12%
• Hematologic Disease 12%